☆ 4.8 Meeting Abstract

Gemcitabine primes the pancreatic tumor microenvironment for second-line immunotherapy

CANCER RESEARCH (2019)

Journal

CANCER RESEARCH

Volume 79, Issue 24, Pages -

Publisher

AMER ASSOC CANCER RESEARCH

DOI: 10.1158/1538-7445.PANCA19-A20

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.